WallStreetZenWallStreetZen

NASDAQ: ALNY
Alnylam Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ALNY

Based on 18 analysts offering 12 month price targets for Alnylam Pharmaceuticals Inc.
Min Forecast
$150.00-36.63%
Avg Forecast
$259.22+9.51%
Max Forecast
$400.00+68.99%

Should I buy or sell ALNY stock?

Based on 18 analysts offering ratings for Alnylam Pharmaceuticals Inc.
Buy
Strong Buy
7 analysts 38.89%
Buy
5 analysts 27.78%
Hold
6 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALNY stock forecasts and price targets.

ALNY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-07-12
lockedlocked$00.00+00.00%2024-07-08
lockedlocked$00.00+00.00%2024-07-03
lockedlocked$00.00+00.00%2024-07-01
lockedlocked$00.00+00.00%2024-06-28
RBC Capital
Bottom 4%
4
BuyMaintains$265.00+11.96%2024-06-27
Stifel Nicolaus
Bottom 14%
14
Strong BuyMaintains$295.00+24.63%2024-06-27
Citigroup
Bottom 12%
12
Strong BuyMaintains$291.00+22.94%2024-06-25
Anonymous
Bank of America
Strong BuyMaintains$295.00+24.63%2024-06-25
TD Cowen
Bottom 2%
2
Strong BuyMaintains$282.00+19.14%2024-06-25

1 of 2

Forecast return on equity

Is ALNY forecast to generate an efficient return?
Company
-448.08%
Industry
70.82%
Market
80.39%
ALNY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALNY forecast to generate an efficient return on assets?
Company
25.69%
Industry
30.66%
ALNY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALNY earnings per share forecast

What is ALNY's earnings per share in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
-$3.99
Avg 2 year Forecast
-$2.39
Avg 3 year Forecast
$3.16

ALNY revenue forecast

What is ALNY's revenue in the next 3 years based on estimates from 12 analysts?
Avg 1 year Forecast
$1.9B-6.18%
Avg 2 year Forecast
$2.2B+11.82%
Avg 3 year Forecast
$3.2B+58.77%
ALNY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALNY revenue growth forecast

How is ALNY forecast to perform vs Biotechnology companies and vs the US market?
Company
15%
Industry
64.53%
Market
11.29%
ALNY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALNY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALNY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALNY$236.70$259.22+9.51%Buy
ARGX$466.56$507.39+8.75%Strong Buy
BNTX$86.37$111.88+29.53%Hold
GMAB$27.24$46.00+68.87%Buy
RPRX$28.33$41.80+47.55%Strong Buy

Alnylam Pharmaceuticals Stock Forecast FAQ

Is Alnylam Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NASDAQ: ALNY) stock is to Buy ALNY stock.

Out of 18 analysts, 7 (38.89%) are recommending ALNY as a Strong Buy, 5 (27.78%) are recommending ALNY as a Buy, 6 (33.33%) are recommending ALNY as a Hold, 0 (0%) are recommending ALNY as a Sell, and 0 (0%) are recommending ALNY as a Strong Sell.

If you're new to stock investing, here's how to buy Alnylam Pharmaceuticals stock.

What is ALNY's earnings growth forecast for 2024-2026?

(NASDAQ: ALNY) Alnylam Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.72%.

Alnylam Pharmaceuticals's earnings in 2024 is -$332,076,000.On average, 11 Wall Street analysts forecast ALNY's earnings for 2024 to be -$504,816,037, with the lowest ALNY earnings forecast at -$718,473,299, and the highest ALNY earnings forecast at -$395,919,265. On average, 12 Wall Street analysts forecast ALNY's earnings for 2025 to be -$302,214,156, with the lowest ALNY earnings forecast at -$478,138,921, and the highest ALNY earnings forecast at -$43,007,205.

In 2026, ALNY is forecast to generate $399,347,192 in earnings, with the lowest earnings forecast at $21,503,602 and the highest earnings forecast at $1,163,724,358.

What is ALNY's revenue growth forecast for 2024-2026?

(NASDAQ: ALNY) Alnylam Pharmaceuticals's forecast annual revenue growth rate of 15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.53%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.29%.

Alnylam Pharmaceuticals's revenue in 2024 is $2,003,335,000.On average, 12 Wall Street analysts forecast ALNY's revenue for 2024 to be $237,751,289,601, with the lowest ALNY revenue forecast at $231,353,461,962, and the highest ALNY revenue forecast at $246,005,004,608. On average, 12 Wall Street analysts forecast ALNY's revenue for 2025 to be $283,350,943,112, with the lowest ALNY revenue forecast at $245,773,524,654, and the highest ALNY revenue forecast at $319,783,863,962.

In 2026, ALNY is forecast to generate $402,325,188,253 in revenue, with the lowest revenue forecast at $332,009,294,306 and the highest revenue forecast at $573,690,809,941.

What is ALNY's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALNY) forecast ROA is 25.69%, which is lower than the forecast US Biotechnology industry average of 30.66%.

What is ALNY's Price Target?

According to 18 Wall Street analysts that have issued a 1 year ALNY price target, the average ALNY price target is $259.22, with the highest ALNY stock price forecast at $400.00 and the lowest ALNY stock price forecast at $150.00.

On average, Wall Street analysts predict that Alnylam Pharmaceuticals's share price could reach $259.22 by Jul 12, 2025. The average Alnylam Pharmaceuticals stock price prediction forecasts a potential upside of 9.51% from the current ALNY share price of $236.70.

What is ALNY's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ALNY) Alnylam Pharmaceuticals's current Earnings Per Share (EPS) is -$2.64. On average, analysts forecast that ALNY's EPS will be -$3.99 for 2024, with the lowest EPS forecast at -$5.68, and the highest EPS forecast at -$3.13. On average, analysts forecast that ALNY's EPS will be -$2.39 for 2025, with the lowest EPS forecast at -$3.78, and the highest EPS forecast at -$0.34. In 2026, ALNY's EPS is forecast to hit $3.16 (min: $0.17, max: $9.20).

What is ALNY's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALNY) forecast ROE is -448.08%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.